INTERNATIONAL PATENT: SHANGHAI NK CELLTECH CO., LTD., 上海恩凯细胞技术有限公司 FILES APPLICATION FOR "TRANSGENIC RECOMBINANT IMMUNE CELL SPECIFICALLY TARGETING TUMOR AND USE THEREOF"

GENEVA, July 8 -- SHANGHAI NK CELLTECH CO., LTD. (No.7, Lane 100, Banxia Road, Zhoupu TownPudong New Area, Shanghai 201318), 上海恩凯细胞技术有限公司 (中国上海市浦东新区周浦镇半夏路100弄7号) filed a patent application (PCT/CN2024/143148) for "TRANSGENIC RECOMBINANT IMMUNE CELL SPECIFICALLY TARGETING TUMOR AND USE THEREOF" on Dec 27, 2024. With publication no. WO/2025/140540, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is manag...